PLEASE USE A NAME WHEN COMMENTING

08 March 2021

“Health Ministry” Report and Other Valuable Information

 

The Jerusalem Post Report of the 

"Health Ministry”: 

see important video and article at end


COVID-19 Vaccination: 73 cases of Facial Paralysis, 7 Anaphylactic Shock
Serious symptoms of the vaccine include blurred vision, inflammation of the pulmonary pleura, inflammation of the heart, heart attack, or even liver damage. https://www.jpost.com/health-science/covid-19-vaccination-73-cases-facial-paralysis-7-anaphylactic-shock-661073

Only 153 people (0.0032%) out of more than 4.7 million who received a first shot of the Pfizer coronavirus vaccine had any kind of serious side effects, according to a new report published by the Health Ministry.

Only 162 had serious side effects from the second dose out of 3.4 million.

The types of serious issues that people experienced ranged from blurred vision, inflammation of the pulmonary pleura (that allow optimal expansion and contraction of the lung during breathing), inflammation of the heart, heart attack or even liver damage.

Some 62 people were hospitalized after receiving their first dose; 75% of them had underlying medical conditions before getting the jab.

Forty-two people were hospitalized after the second shot.

Some 487 (first) and 250 (second) had neurological issues after getting inoculated: 474 people who experienced paresthesia (tingling, pricking, chilling, burning, numbness of the skin), 73 who had Bell’s palsy (facial paralysis), 23 convulsions, 28 metal taste in the mouth, 14 loss of consciousness, five transient cerebral ischemia (temporary stroke) and 59 others who had unidentified neurological issues.

In total, 9,595 people reported side effects from the vaccines out of 4,755,585 people who received the first dose, and another 8,743 out of 3,408,825 who received the second dose.

The majority of complaints were among younger people (20-49) and women.

The report was updated as of March 1.

The majority of side effects are not severe but rather mild and most often near the site of the jab. Some 4,256 (first) and 2,092 (second) had pain or other reactions at the site of the shot.

Some 4,436 people (first) and 6,122 expressed general symptoms, such as fever or achiness.

Around 220 (first) and 101 (second) had an allergic reaction, possibly even anaphylactic shock - 4 cases after the first shot and three after the second. More common was tingling, swelling of the upper respiratory tract and itching.

The rate of reports of mild side effects that appear in close proximity to the vaccine is lower than that observed in clinical trials. However, the Health Ministry said that it is likely that there was some under-reporting by the public, especially people who did not require any medical intervention.

More than 4.9 million Israelis have had at least one shot of the Pfizer vaccine and another 3.6 million the second shot.

The Health Ministry provided a breakdown of vaccination by age. The following percentages of people by age have had their second shot and are considered fully vaccinated:

> 90+ - 82.1%
> 80-89 - 81.4%
> 70-79 - 84.6%
> 60-69 - 72%
> 50-59 - 58.3%
> 40-49 - 43.1%
> 30-39 - 22.6%
> 20-29 - 17.3%
> Under 19 - 1.9%

[me: The above numbers are probably what has been published with Pfizer/CDC to their satisfaction. But there is a gigantic gap between this and what others are reporting]

––––––––––––––––––––––––––––––––––––––––––––––––––––
Are the figures correct? 
What was not included? Left out?
Were they manipulated to produce results the Ministry of Health wants to project because they know there “adverse effects” so denying them would be lying.

Listen to this video (Ivrit) explain otherwise.
Then listen to Post entitled “Some Reminders"

 

COVID-19 RNA Based Vaccines and the Risk of Prion Disease

Research Article 

ISSN 2639-9458

J. Bart Classen, MD*


Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARS- CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing. In this paper the Pfizer COVID-19 vaccine was evaluated for the potential to induce prion-based disease in vaccine recipients. The RNA sequence of the vaccine as well as the spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations. The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified. Two GGΨA sequences were found. Potential G Quadruplex sequences are possibly present but a more sophisticated computer program is needed to verify these. Furthermore, the spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme. This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases. The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines 

.   for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit


Results

Analysis of the Pfizer vaccine against COVID-19 identified two potential risk factors for inducing prion disease is humans. 

ONE SHOULD READ THE FULL ABSTRACT https://files.constantcontact.com/daa02ded201/f8c8ff7b-10cd-4bdf-bad5-57ae8467a86a.pdf

No comments:

Eliezer Meir Saidel: A Smell of Gan Eden – Chayei Sarah

  A Smell of Gan Eden – Chayei Sarah וְיִתֶּן לִי אֶת מְעָרַת הַמַּכְפֵּלָה אֲשֶׁר לוֹ אֲשֶׁר בִּקְצֵה שָׂדֵהוּ בְּכֶסֶף מָלֵא י...